| Primary |
| Product Used For Unknown Indication |
49.2% |
| Anaesthesia |
6.3% |
| Hypertension |
6.3% |
| Bronchiolitis |
4.8% |
| Cough |
4.8% |
| Ear Infection |
4.8% |
| Pain |
4.8% |
| Arthritis |
3.2% |
| Neuralgia |
3.2% |
| Otitis Media |
3.2% |
| Rhinitis |
3.2% |
| Bronchitis |
1.6% |
| Dyslipidaemia |
1.6% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.6% |
| Nasopharyngitis |
1.6% |
|
| Hyponatraemia |
11.8% |
| Medication Error |
11.8% |
| Accidental Overdose |
5.9% |
| Foetal Growth Restriction |
5.9% |
| Hepatocellular Injury |
5.9% |
| No Adverse Event |
5.9% |
| Oedematous Pancreatitis |
5.9% |
| Osteonecrosis |
5.9% |
| Pancreatitis |
5.9% |
| Pancreatitis Acute |
5.9% |
| Paraesthesia |
5.9% |
| Sickle Cell Anaemia With Crisis |
5.9% |
| Transaminases Increased |
5.9% |
| Urticaria |
5.9% |
| Ventricular Extrasystoles |
5.9% |
|
| Secondary |
| Product Used For Unknown Indication |
29.1% |
| Maternal Exposure Timing Unspecified |
16.2% |
| Foetal Exposure During Pregnancy |
12.6% |
| Anaesthesia |
7.7% |
| Drug Exposure Via Mother |
5.5% |
| Drug Use For Unknown Indication |
4.0% |
| Premedication |
3.6% |
| Viral Tonsillitis |
3.6% |
| Pain |
3.0% |
| Pyrexia |
2.2% |
| Hypertension |
1.8% |
| Nausea |
1.8% |
| Cough |
1.6% |
| Asthma |
1.2% |
| Bronchitis |
1.2% |
| Maternal Exposure Before Pregnancy |
1.2% |
| Threatened Labour |
1.2% |
| Ill-defined Disorder |
1.0% |
| Pruritus |
1.0% |
| Arthritis |
0.8% |
|
| Premature Baby |
19.2% |
| Maternal Exposure Timing Unspecified |
9.6% |
| Hepatocellular Injury |
8.2% |
| Rectal Haemorrhage |
8.2% |
| Foetal Growth Restriction |
6.8% |
| Osteonecrosis |
6.8% |
| Vomiting |
6.8% |
| Hyponatraemia |
5.5% |
| Rash |
4.1% |
| Stevens-johnson Syndrome |
4.1% |
| Acute Pulmonary Oedema |
2.7% |
| Hepatitis Cholestatic |
2.7% |
| Pregnancy |
2.7% |
| Skin Lesion |
2.7% |
| Urinary Tract Infection Pseudomonal |
2.7% |
| Acute Generalised Exanthematous Pustulosis |
1.4% |
| Allergic Granulomatous Angiitis |
1.4% |
| Arthritis Bacterial |
1.4% |
| Hepatitis |
1.4% |
| Hypospadias |
1.4% |
|
| Concomitant |
| Bronchitis |
13.1% |
| Product Used For Unknown Indication |
12.2% |
| Hiv Infection |
9.3% |
| Hypertension |
8.4% |
| Prophylaxis |
6.8% |
| Nasopharyngitis |
6.3% |
| Acute Sinusitis |
5.1% |
| Threatened Labour |
4.6% |
| Drug Use For Unknown Indication |
3.8% |
| Rhinitis Allergic |
3.4% |
| Unevaluable Event |
3.4% |
| Otitis Media Acute |
3.0% |
| Pain Prophylaxis |
3.0% |
| Liposarcoma |
2.5% |
| Mitochondrial Cytopathy |
2.5% |
| Osteoporosis |
2.5% |
| Pneumonia |
2.5% |
| Premature Labour |
2.5% |
| Premedication |
2.5% |
| Pulmonary Arterial Hypertension |
2.5% |
|
| Osteonecrosis |
9.6% |
| Thrombocythaemia |
9.6% |
| Vomiting |
9.6% |
| Pyrexia |
5.8% |
| Tachypnoea |
5.8% |
| Ventricular Septal Defect |
5.8% |
| Bone Infarction |
3.8% |
| Cytolytic Hepatitis |
3.8% |
| Gait Disturbance |
3.8% |
| Hypospadias |
3.8% |
| Nausea |
3.8% |
| Overdose |
3.8% |
| Pulmonary Embolism |
3.8% |
| Pulmonary Hypertension |
3.8% |
| Purpura Non-thrombocytopenic |
3.8% |
| Renal Failure Acute |
3.8% |
| Rhabdomyolysis |
3.8% |
| Skin Lesion |
3.8% |
| Somnolence |
3.8% |
| Suicide Attempt |
3.8% |
|
| Interacting |
|
|
